Provectus Biopharmaceuticals (PVCT) Stock Chart & Stock Price History $0.11 0.00 (-2.19%) As of 01/21/2025 03:27 PM Eastern Add Compare Share Share Chart Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Provectus Biopharmaceuticals Stock Price Performance 5 Day Performance-2.19%1 Month Performance-6.83%3 Month Performance+4.49%6 Month Performance+6.68%Year-To-Date Performance-6.91%1 Year Performance+5.37% Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address PVCT Stock Chart for Wednesday, January, 22, 2025 PVCT Chart by TradingView Provectus Biopharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/21/2025$0.11$0.11-2.19%$0.12$0.11454,705 shs$46.99 million01/20/2025$0.11$0.11$0.12$0.11153,550 shs$50.07 million01/17/2025$0.12$0.11-2.39%$0.12$0.11153,550 shs$50.07 million01/16/2025$0.12$0.12+1.04%$0.12$0.1242,939 shs$51.30 million01/15/2025$0.12$0.12-1.19%$0.12$0.1220,190 shs$50.77 million01/14/2025$0.11$0.12+2.27%$0.12$0.1278,450 shs$51.39 million01/13/2025$0.11$0.11+2.14%$0.11$0.1166,799 shs$50.25 million01/10/2025$0.11$0.11+0.18%$0.12$0.11343,569 shs$49.20 million01/09/2025$0.11$0.11$0.12$0.11491,251 shs$49.11 million01/08/2025$0.11$0.11-1.75%$0.12$0.11491,251 shs$49.11 million Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/07/2025$0.12$0.11-4.92%$0.12$0.11179,471 shs$49.99 million01/06/2025$0.12$0.12$0.12$0.1273,486 shs$52.57 million01/03/2025$0.12$0.12-0.33%$0.12$0.1237,450 shs$52.57 million01/02/2025$0.12$0.12+0.25%$0.12$0.12399,150 shs$52.75 million01/01/2025$0.12$0.12$0.12$0.12245,657 shs$52.61 million12/31/2024$0.12$0.12-1.48%$0.12$0.12245,657 shs$52.61 million12/30/2024$0.12$0.12$0.12$0.1233,968 shs$53.40 million12/27/2024$0.12$0.12-0.41%$0.12$0.1229,945 shs$53.40 million12/26/2024$0.12$0.12+2.26%$0.12$0.12162,587 shs$53.62 million12/25/2024$0.12$0.12$0.12$0.12104,951 shs$52.44 million12/24/2024$0.12$0.12-3.39%$0.12$0.12104,951 shs$52.44 million12/23/2024$0.12$0.12+3.25%$0.12$0.1294,621 shs$54.28 million Related Companies MDWD Stock Price Chart IKT Stock Price Chart MGNX Stock Price Chart CYDY Stock Price Chart ACRS Stock Price Chart CYBN Stock Price Chart ACRV Stock Price Chart ADCT Stock Price Chart CRDF Stock Price Chart NKTX Stock Price Chart Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PVCT) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
